Keyphrases
Hypertrophic Cardiomyopathy
100%
Temporal Change
100%
Hypertrophic Obstructive Cardiomyopathy
100%
Left Atrial Function
100%
Mavacamten
100%
Left Atrial Strain
66%
Strain Value
33%
Placebo
22%
Atrial Fibrillation
22%
Symptomatic Patients
22%
Volume Index
22%
Septal Reduction Therapy
22%
LA Volume
22%
Left Atrial Remodeling
22%
Echocardiographic
11%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
11%
Long-term Treatment
11%
Troponin
11%
Left Atrial
11%
Cardiac Remodeling
11%
High Burden
11%
Sustained Improvement
11%
Atrial Arrhythmia
11%
Improved Function
11%
Left Atrial Volume Index
11%
Strain Measure
11%
Post-processing Software
11%
Serial Changes
11%
Vendor-neutral
11%
Left Ventricular Outflow Tract Gradient
11%
Medicine and Dentistry
Hypertrophic Cardiomyopathy
100%
Hypertrophic Obstructive Cardiomyopathy
100%
Heart Atrium Function
100%
Mavacamten
100%
Placebo
22%
Atrial Fibrillation
22%
Heart Atrium Remodeling
22%
Biological Marker
11%
Ventricular Outflow Tract
11%
Heart Ventricle Remodeling
11%
Amino Terminal Sequence
11%
Natriuretic Factor
11%
Troponin T
11%
Tachycardia
11%
Peptide T
11%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertrophic Obstructive Cardiomyopathy
100%
Hypertrophic Cardiomyopathy
100%
Mavacamten
100%
Placebo
22%
Atrial Fibrillation
22%
Heart Atrium Remodeling
22%
Biological Marker
11%
Natriuretic Factor
11%
Troponin T
11%
Heart Ventricle Remodeling
11%
Peptide T
11%